Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP686949.RA6ZVlDtYZ0mNJOWUycE3xMwy9JUqBqmcJjur3ta9IqyY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP686949.RA6ZVlDtYZ0mNJOWUycE3xMwy9JUqBqmcJjur3ta9IqyY130_assertion type Assertion NP686949.RA6ZVlDtYZ0mNJOWUycE3xMwy9JUqBqmcJjur3ta9IqyY130_head.
- NP686949.RA6ZVlDtYZ0mNJOWUycE3xMwy9JUqBqmcJjur3ta9IqyY130_assertion description "[In this work, we conduct a case-control study to assess the impact of CYP1A1*2A (CYP1A1 T6235C); NQO1*2 (NQO1 C609T); TPMT*2 (TPMT G238C) and TPMT A719G polymorphisms on the risk of developing ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP686949.RA6ZVlDtYZ0mNJOWUycE3xMwy9JUqBqmcJjur3ta9IqyY130_provenance.
- NP686949.RA6ZVlDtYZ0mNJOWUycE3xMwy9JUqBqmcJjur3ta9IqyY130_assertion evidence source_evidence_literature NP686949.RA6ZVlDtYZ0mNJOWUycE3xMwy9JUqBqmcJjur3ta9IqyY130_provenance.
- NP686949.RA6ZVlDtYZ0mNJOWUycE3xMwy9JUqBqmcJjur3ta9IqyY130_assertion SIO_000772 23065291 NP686949.RA6ZVlDtYZ0mNJOWUycE3xMwy9JUqBqmcJjur3ta9IqyY130_provenance.
- NP686949.RA6ZVlDtYZ0mNJOWUycE3xMwy9JUqBqmcJjur3ta9IqyY130_assertion wasDerivedFrom befree-20140225 NP686949.RA6ZVlDtYZ0mNJOWUycE3xMwy9JUqBqmcJjur3ta9IqyY130_provenance.
- NP686949.RA6ZVlDtYZ0mNJOWUycE3xMwy9JUqBqmcJjur3ta9IqyY130_assertion wasGeneratedBy ECO_0000203 NP686949.RA6ZVlDtYZ0mNJOWUycE3xMwy9JUqBqmcJjur3ta9IqyY130_provenance.